PERCEIVED PRACTICE OF MALAYSIAN COMMUNITY PHARMACISTS TOWARDS THE SALE OF PEDIATRIC COUGH AND COLD PRODUCTS

Author(s)

Shaikh FA1, Ahmad S2, Loh LV2, Qamar M3, Hammad M4
1Management & Science University, University Drive, Shah Alam, Malaysia, 2MAHSA University, Selangor, Malaysia, 3MAHSA University, Selangor, 10, Malaysia, 4Universiti Sains Malaysia, Penang, Malaysia

OBJECTIVES: Despite insufficient evidence to support the safety and efficacy of cough and cold (CAC) products in pediatrics, these are frequently used to relieve CAC symptoms.The objective of this study is to assess the perceived practice of community pharmacists and their comfort level towards dispensing of CAC products in pediatric patient in less than 6 years old.

METHODS: A cross-sectional survey was carried out. A total 216 community pharmacists were enrolled by convenience sampling. Self-administered and pre-validated questionnaire comprising of three sections including socio-demographic information and pharmacists’ comfort level in recommending CAC products. Data were expressed using descriptive as well as inferential statistics.

RESULTS: Based on safety and efficacy, the enrolled pharmacists feel more comfortable to dispense, but uncomfortable to recommend the products for < 2 years than for 2 to 5 years. Overall, pharmacist feel comfortable to suggest vitamin and minerals, herbal remedies and non-pharmacological remedies for pediatric of both age groups. Majority of pharmacist support behind the counter status for CAC products. There is significant association between community pharmacist's experience and the perceived practice of safety and effectiveness to suggest CAC products for pediatric (p<0.05).Chain pharmacist (23.9%) were significantly (p=0.0006) counselled on 50% or more of CAC products than independent pharmacists (12.5%).

CONCLUSIONS: The perceived practice of community pharmacist is acceptable. Education and counselling should be given to the patients to prevent misuse/overdose in order to optimize the therapeutic outcome.

Conference/Value in Health Info

2018-09, ISPOR Asia Pacific 2018, Tokyo, Japan

Value in Health, Vol. 21, S2 (September 2018)

Code

PIH4

Topic

Epidemiology & Public Health

Topic Subcategory

Safety & Pharmacoepidemiology

Disease

Multiple Diseases, Pediatrics, Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×